| 2026-03-26 |
详情>>
业绩披露：
2025年年报每股收益-2.36欧元,归母净利润-9008.5万欧元,同比去年增长-52.08%
|
| 2026-03-19 |
详情>>
股本变动：
变动后总股本4366.24万股
|
| 2026-03-19 |
财报披露：
美东时间 2026-03-19 盘后发布财报
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.78欧元,归母净利润-6657.2万欧元,同比去年增长-58.18%
|
| 2025-08-18 |
详情>>
业绩披露：
2025年中报每股收益-1.15欧元,归母净利润-4299.1万欧元,同比去年增长-71.76%
|
| 2025-06-16 |
股东大会：
将于2025-07-02召开股东大会
会议内容 ▼▲
- 1.Adding paragraphs at the end of article 13 of the articles of association of the Company to introduce the right to nominate directors for shareholders having held at least five percent (5%) of the outstanding shares of the Company in registered form continuously for a period of at least three (3) years.
2.Power of attorney to the notary
Proposed decision: The shareholders’ meeting decides to grant the acting notary, and any other notary of “Berquin Notarissen”, all powers to draw up and sign a restated version of the articles of association of the Company and to file them in the appropriate data base in accordance with applicable law.
|
| 2025-06-16 |
股东大会：
将于2025-07-02召开股东大会
会议内容 ▼▲
- 1.Adding paragraphs at the end of article 13 of the articles of association of the Company to introduce the right to nominate directors for shareholders having held at least five percent (5%) of the outstanding shares of the Company in registered form continuously for a period of at least three (3) years.
2.Power of attorney to the notary
Proposed decision: The shareholders’ meeting decides to grant the acting notary, and any other notary of “Berquin Notarissen”, all powers to draw up and sign a restated version of the articles of association of the Company and to file them in the appropriate data base in accordance with applicable law.
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.6欧元,归母净利润-2238.4万欧元,同比去年增长-88.01%
|
| 2025-05-09 |
股东大会：
将于2025-06-11召开股东大会
会议内容 ▼▲
- 1.Acknowledgement and discussion of;
2.Approval of the statutory annual accounts for the financial year ended on December 31, 2024 and the proposed allocation of the result;
3.Discharge of directors;
4.Discharge of the statutory auditor;
5.Acknowledgement and approval of the remuneration report;
6.Acknowledgement and approval of the amended remuneration policy to allow for the extension of the contractually agreed notice period (or corresponding payments in lieu of notice) or severance payment with members of executive management and to make certain other changes;
7.Authorization of the Board, in accordance with Article 7:92 and Article 7:151 of the CCA, to enter into an addendum to the agreements entered into with Mr. Olivier Taelman, CEO of the Company, to provide for a severance payment amounting to 18 months’ remuneration in case of termination of the agreements without cause within three (3) months of a change of control;
8.Approval, in accordance with Article 7:92 of the CCA, of the agreement entered into with Mr. John Landry, CFO of the Company that provides for a severance payment amounting to 18 months’ remuneration in case of termination of the agreement without cause within three (3) months of a change of control;
9.Reappointment of Robelga SRL (permanently represented by Robert Taub) as director;
10.Reappointment of Jürgen Hambrecht as independent director;
11.Reappointment of Kevin Rakin as independent director;
12.Reappointment of Rita Johnson-Mills as independent director;
13.Reappointment of Virginia Kirby as independent director;
14.Reappointment of Wildman Ventures LLC (permanently represented by Daniel Wildman) as independent director;
15.Reappointment of Pierre Gianello as director;
16.Reappointment of Olivier Taelman as director;
17.Approval of the statutory auditor's remuneration for the financial year ended on December 31, 2024;
18.Re-appointment of Ernst et Young Réviseurs d'Entreprises SRL, with as permanent representative Mr. Thomas Meurice, as statutory auditor, upon proposal of the board of directors of the Company based on the proposal received from the Audit Committee, and decision on the remuneration for the exercise of the mandate as statutory auditor.
|
| 2025-05-09 |
股东大会：
将于2025-06-11召开股东大会
会议内容 ▼▲
- 1.Acknowledgement and discussion of;
2.Approval of the statutory annual accounts for the financial year ended on December 31, 2024 and the proposed allocation of the result;
3.Discharge of directors;
4.Discharge of the statutory auditor;
5.Acknowledgement and approval of the remuneration report;
6.Acknowledgement and approval of the amended remuneration policy to allow for the extension of the contractually agreed notice period (or corresponding payments in lieu of notice) or severance payment with members of executive management and to make certain other changes;
7.Authorization of the Board, in accordance with Article 7:92 and Article 7:151 of the CCA, to enter into an addendum to the agreements entered into with Mr. Olivier Taelman, CEO of the Company, to provide for a severance payment amounting to 18 months’ remuneration in case of termination of the agreements without cause within three (3) months of a change of control;
8.Approval, in accordance with Article 7:92 of the CCA, of the agreement entered into with Mr. John Landry, CFO of the Company that provides for a severance payment amounting to 18 months’ remuneration in case of termination of the agreement without cause within three (3) months of a change of control;
9.Reappointment of Robelga SRL (permanently represented by Robert Taub) as director;
10.Reappointment of Jürgen Hambrecht as independent director;
11.Reappointment of Kevin Rakin as independent director;
12.Reappointment of Rita Johnson-Mills as independent director;
13.Reappointment of Virginia Kirby as independent director;
14.Reappointment of Wildman Ventures LLC (permanently represented by Daniel Wildman) as independent director;
15.Reappointment of Pierre Gianello as director;
16.Reappointment of Olivier Taelman as director;
17.Approval of the statutory auditor's remuneration for the financial year ended on December 31, 2024;
18.Re-appointment of Ernst et Young Réviseurs d'Entreprises SRL, with as permanent representative Mr. Thomas Meurice, as statutory auditor, upon proposal of the board of directors of the Company based on the proposal received from the Audit Committee, and decision on the remuneration for the exercise of the mandate as statutory auditor.
|
| 2025-03-20 |
详情>>
业绩披露：
2022年年报每股收益-1.21欧元,归母净利润-3122.5万欧元,同比去年增长-13.06%
|
| 2025-03-20 |
详情>>
业绩披露：
2024年年报每股收益-1.81欧元,归母净利润-5923.6万欧元,同比去年增长-37.08%
|
| 2024-11-20 |
股东大会：
将于2024-12-19召开股东大会
会议内容 ▼▲
- 1.Approval of all relevant clauses in the EIB Agreements in accordance with Article 7:151 of the Belgian Code of Companies and Associations.
|
| 2024-11-20 |
股东大会：
将于2024-12-19召开股东大会
会议内容 ▼▲
- 1.Approval of all relevant clauses in the EIB Agreements in accordance with Article 7:151 of the Belgian Code of Companies and Associations.
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.35欧元,归母净利润-4208.7万欧元,同比去年增长-30.22%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.84欧元,归母净利润-2503万欧元,同比去年增长-1.31%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.41欧元,归母净利润-1190.6万欧元,同比去年增长0.04%
|
| 2024-03-20 |
详情>>
业绩披露：
2023年年报每股收益-1.54欧元,归母净利润-4321.2万欧元,同比去年增长-38.39%
|
| 2023-05-15 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.Acknowledgement and discussion of:
a.the statutory annual accounts for the financial year ended on December 31, 2022;
b.the consolidated financial statements for the financial year ended on December 31, 2022;
c.the annual report of the board of directors on the statutory annual accounts for the financial year ended on December 31, 2022;
d.the annual report of the board of directors on the consolidated financial statements for the financial year ended on December 31, 2022;
e.the statutory auditor's report on the statutory annual accounts for the financial year ended on December 31, 2022;
f.the statutory auditor's report on the consolidated financial statements for the financial year ended on December 31, 2022.
2.Approval of the statutory annual accounts for the financial year ended on December 31, 2022 and the proposed allocation of the result.
3.Discharge of directors.
4.Discharge of the statutory auditor.
5.Acknowledgement and approval of the remuneration report.
6.Acknowledgement and approval of the amended remuneration policy.
7.Appoitment of director.
|
| 2023-05-15 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.Acknowledgement and discussion of:
a.the statutory annual accounts for the financial year ended on December 31, 2022;
b.the consolidated financial statements for the financial year ended on December 31, 2022;
c.the annual report of the board of directors on the statutory annual accounts for the financial year ended on December 31, 2022;
d.the annual report of the board of directors on the consolidated financial statements for the financial year ended on December 31, 2022;
e.the statutory auditor's report on the statutory annual accounts for the financial year ended on December 31, 2022;
f.the statutory auditor's report on the consolidated financial statements for the financial year ended on December 31, 2022.
2.Approval of the statutory annual accounts for the financial year ended on December 31, 2022 and the proposed allocation of the result.
3.Discharge of directors.
4.Discharge of the statutory auditor.
5.Acknowledgement and approval of the remuneration report.
6.Acknowledgement and approval of the amended remuneration policy.
7.Appoitment of director.
|
| 2022-05-06 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.Acknowledgement and discussion of:
a.the statutory annual accounts for the financial year ended on December 31, 2021;
b.the consolidated financial statements for the financial year ended on December 31, 2021;
c.the annual report of the board of directors on the statutory annual accounts for the financial year ended on December 31, 2021;
d.the annual report of the board of directors on the consolidated financial statements for the financial year ended on December 31, 2021;
e.the statutory auditor's report on the statutory annual accounts for the financial year ended on December 31, 2021;
f.the statutory auditor's report on the consolidated financial statements for the financial year ended on December 31, 2021.
2.Approval of the statutory annual accounts for the financial year ended on December 31, 2021 and the proposed allocation of the result
3.Discharge of directors
4.Discharge of the statutory auditor
5.Acknowledgement and approval of the remuneration report
6.Acknowledgement and approval of the amended remuneration policy
7.Approval of directors' and committee members' cash remuneration
8.Approval of non-executive directors' remuneration in the form of warrants
9.Acknowledgement of the resignation of directors
10.Appointment of directors
11.Approval of the statutory auditor's remuneration for the financial year ended on December 31, 2021
12.Re-appointment of Ernst & Young Réviseurs d'Entreprises SRL, with as representative Mr. Carlo-Sébastien D'Addario, as auditor, upon proposal of the board of directors of the Company based on the proposal received from the Audit Committee, and decision on the remuneration for the exercise of the mandate as auditor
13.Acknowledgment and discussion of the special report by the board of directors drawn up in accordance with articles 7:179 and 7:191 of the Belgian Code of Companies and Associations with respect to the proposed issuance of shares and cancellation of the preferential subscription rights
14.Acknowledgment and discussion of the auditor's report drawn up in accordance with articles 7:179 and 7:191 of the Belgian Code of Companies and Associations with respect to the proposed issuance of shares and cancellation of the preferential subscription rights
15.Increase of the capital in an amount of EUR 6,686.47, by way of a contribution in cash against issuance of 38,920 new shares, with cancellation of the preferential subscription right of the existing shareholders for the benefit of the non-executive directors of the Company, provided that the proposed decisions regarding this agenda item (and regarding the following agenda items) shall only be submitted to the vote of the shareholders' meeting if the amended remuneration policy (including in particular the proposed subscription of shares by the non-executive directors at a discounted subscription price as part of their remuneration package) has been approved by the shareholders' meeting that will decide on the approval of the annual accounts for the financial year ended on December 31, 2021
16.Amendment of article 5 of the articles of association to bring it in line with the aforementioned decisions
17.Power of attorney to the notary
18.Power of attorney to the directors
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|